Also trades as: MGROF (OTC) · $vol 0M
MGRO.V TSXV
MustGrow Biologics Corp.
1W: +6.0%
1M: +7.3%
3M: +10.0%
YTD: -31.2%
1Y: -38.9%
3Y: -73.3%
C$0.44 ($0.31)
-0.00 (-0.00%)
Weekly Expected Move ±10.6%
C$0
C$0
C$0
C$0
C$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$398K
-91.6% ▼
Gross Profit
$301K
-93.1% ▼
Operating Income
-$5M
-535.3% ▼
Net Income
-$5M
-622.2% ▼
EPS (Diluted)
$-0.09
-596.3% ▼
EBITDA
-$5M
-655.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $13K | $6K | $5M | $398K |
| YoY Growth | +0.0% | +0.0% | -49.7% | +72630.4% | -91.6% |
| Cost of Revenue | $0 | $0 | $0 | $385K | $97K |
| Gross Profit | $0 | $13K | $6K | $4M | $301K |
| Gross Margin | — | 100.0% | 100.0% | 91.8% | 75.6% |
| R&D Expenses | $149K | $458K | $476K | $857K | $774K |
| SG&A Expenses | $3M | $3M | $5M | $4M | $4M |
| Operating Expenses | $3M | $3M | $6M | $6M | $5M |
| Operating Income | -$3M | -$3M | -$6M | -$805K | -$5M |
| Operating Margin | — | -23398.2% | -85750.5% | -17.1% | -1284.9% |
| Interest Expense | $46K | $53K | $10K | $0 | $0 |
| Income Before Tax | -$3M | -$3M | -$6M | -$677K | -$5M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$3M | -$3M | -$6M | -$677K | -$5M |
| Net Margin | — | -23808.2% | -85905.9% | -14.4% | -1228.3% |
| EPS (Diluted) | $-0.09 | $-0.07 | $-0.11 | $-0.01 | $-0.09 |
| EBITDA | -$3M | -$3M | -$6M | -$677K | -$5M |
| Shares Outstanding | 37M | 44M | 49M | 50M | 52M |